Abdelrahman Ali, Cardiology Fellow at the University of Texas Medical Branch in Galveston, shared a post by International Cardio-Oncology Society on LinkedIn, adding:
“Incredibly humbled and honored to share that our paper has just been published!
“Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers”
This work is very dear to my heart – bridging the gap between cardiology and oncology is not just an academic pursuit, it is a clinical imperative for the patients we serve every day.
I would like to sincerely thank Daniel Lenihan for his valuable guidance and contributions throughout this work.
What a moment to share this with the global CardioOnc community gathered here at ACC 2026 – surrounded by the brightest minds working to protect the hearts of cancer patients and survivors. The timing could not feel more meaningful.
This paper is for every hematologist, oncologist, and cardiologist trying to navigate this space together – we hope it serves as a practical, accessible guide.”
Quoting International Cardio-Oncology Society‘s post:
“Breaking News
We are proud to announce our new consensus statement, outlining how hematology and oncology can consistently apply cardio-oncology guidelines to mitigate Cancer therapy-related cardiac dysfunction (CTRCD).”
Title: Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers
Authors: Abdelrahman Ali, Suparna C. Clasen, Anne Blaes, Stephen Casselli, Anita Deswal, Susan Halli Demeter, Gregory Durm, Anecita Fadol, Alessandra Ferrajoli, Michael G. Fradley, Joerg Herrmann, Borja Ibanez, Sue Koob, Bogda Koczwara, Kasey J. Leger, Jennifer E. Liu, Teresa López-Fernández, Alexander R. Lyon, N. G. Choon Ta, John Teerlink, Eric H. Yang, Susan Dent, Daniel Lenihan
Other articles about Hematology on OncoDaily.